Search

everythinglearnresearchcommunity

for

Search:↓

The study suggests hormonal factors may play a role in Frontal Fibrosing Alopecia and that treatments like oral antiandrogens and steroids could be beneficial.

Tofacitinib may help hair regrowth in alopecia areata, but more research is needed.

Temporal triangular alopecia may be linked to sebaceous nevus and shows a new pinkish background feature.

Early treatment of traction alopecia can reverse hair loss; prevention involves avoiding tight hairstyles.

Regulatory T cells help prevent autoimmunity and have potential for treating autoimmune diseases.

Telogen effluvium is a type of hair loss where more hair than normal falls out after stress or illness.

Fibroblast Growth Factors (FGFs) are important for tissue repair and regeneration, influencing cell behavior and other factors involved in healing, and are crucial in processes like wound healing, bone repair, and hair growth.

New criteria for diagnosing frontal fibrosing alopecia include specific scalp and eyebrow hair loss as major factors and other hair loss areas and hair analysis as minor factors.

The commentary suggests that certain hair and skin care products may be linked to frontal fibrosing alopecia, but not sunscreens, and calls for more thorough research on the causes.

Asian patients with Frontal Fibrosing Alopecia often lose eyebrow hair and respond well to combined antiandrogen or antimalarial and topical treatments.

Tofacitinib effectively improved hair regrowth and skin condition in a woman with alopecia totalis and lichen planus hypertrophicus.

A woman with severe hair loss saw significant hair regrowth after adding platelet-rich plasma injections to her treatment with tofacitinib.

Fenoterol treatment causes increased hair growth due to higher metabolism in hair follicles, not hormones.

The STRIAA tool helps doctors quickly and effectively assess the severity of Alopecia Areata.

Tofacitinib was found to be a safe and effective treatment for hair regrowth in patients with alopecia areata.

Tofacitinib and baricitinib are similarly effective and safe for alopecia areata, but baricitinib works faster.

Tofacitinib, an arthritis drug, helped hair growth in alopecia universalis but long-term safety needs more research.

Switching between the medications tofacitinib and baricitinib can be effective for treating hair loss in alopecia areata.

Fucoidan reduces bone cell formation by affecting T-cell activity.

A 13-year-old boy had a rare, stable type of hair loss with little chance of regrowth, but treatment is available for looks.

A woman thought to have rosacea was actually suffering from Frontal Fibrosing Alopecia, a hair loss condition. Despite treatment, her condition didn't change, showing the importance of accurate early diagnosis.

Hair transplantation might work for some people with frontal fibrosing alopecia, but more research is needed.

The study concluded that severity of Frontal fibrosing alopecia is not linked to how long someone has it, can start before menopause, and eyebrow loss may be an early sign.

Act quickly to treat traction alopecia to prevent permanent hair loss.

Athletic trainers should understand and support the medical needs of transgender and gender-diverse patients.

Tofacitinib effectively reduced hair loss in alopecia areata patients without adverse effects.

Targeting METTL1 may help slow papillary thyroid cancer growth and spread.

Frontal fibrosing alopecia can occur in children, not just postmenopausal women.

The extract from Bacillus/Trapa japonica fruit helps increase hair growth and could be a potential treatment for hair loss.

Tofacitinib is effective and safe for treating alopecia areata.